{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:12:10Z","timestamp":1716657130418},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10461-014-0745-8","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T16:29:54Z","timestamp":1396542594000},"page":"1913-1923","source":"Crossref","is-referenced-by-count":6,"title":["Cost-Effectiveness of Interventions to Prevent HIV and STDs Among Women: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"18","author":[{"given":"Jennifer Prah","family":"Ruger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arbi Ben","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Luekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Cottler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"745_CR1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705\u201314.","journal-title":"Ann Intern Med"},{"key":"745_CR2","unstructured":"Australian Commonwealth Department of Health and Ageing. 2002. Return on investment in needle and syringe programs in Australia. Available at http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/2C9410E4A867F2EBCA257650000077B9\/$File\/roirep.pdf . Accessed 22 Feb 2012."},{"key":"745_CR3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007435-199811000-00011","volume":"25","author":"BM Branson","year":"1998","unstructured":"Branson BM, Peterman TA, Cannon RO, Ransom R, Zaidi AA. Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial. Sex Transm Dis. 1998;25:553\u201360.","journal-title":"Sex Transm Dis"},{"key":"745_CR4","unstructured":"Centers for Disease Control and Prevention. 2007. HIV prevalence among selected populations: high-risk populations. Available at http:\/\/www.cdc.gov\/hiv\/topics\/testing\/resources\/reports\/hiv_prevalence\/high-risk.htm . Accessed 22 Feb 2012."},{"key":"745_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-7547-6-10","volume":"6","author":"HW Chesson","year":"2008","unstructured":"Chesson HW, Collins D, Koski K. Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Cost Eff Res Alloc. 2008;6:10.","journal-title":"Cost Eff Res Alloc"},{"key":"745_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-2-24","volume":"2","author":"HW Chesson","year":"2002","unstructured":"Chesson HW, Greenberg JB, Hennessy M. The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women. BMC Infect Dis. 2002;2:24.","journal-title":"BMC Infect Dis"},{"key":"745_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200005010-00009","volume":"24","author":"HW Chesson","year":"2000","unstructured":"Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr. 2000;24:48\u201356.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"745_CR8","unstructured":"City of St. Louis Department of Health. 2005. Program monitoring. Available at http:\/\/stlouis.missouri.org\/citygov\/health\/pdf\/cd\/CDDec2005.pdf Accessed 22 Sep 2010."},{"key":"745_CR9","unstructured":"City of St. Louis Department of Health. 2007. Public Health: Understanding Our Needs. St. Louis. Available at http:\/\/stlouis-mo.gov\/government\/departments\/health\/documents\/upload\/\/UON_VOL_3_20072.pdf.Accessed 22 Feb 2012."},{"key":"745_CR10","unstructured":"Diaz A, Junquera ML, Esteban V, Mart\u00ednez B, Pueyo I, Suarez J, STI Study Group and EPI-VIH Group. HIV\/STI co-infection among men who have sex with men in Spain. Euro Surveill. 2009;14, pii 19426."},{"key":"745_CR11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(09)70264-6","volume":"9","author":"J Dionne-Odom","year":"2009","unstructured":"Dionne-Odom J, Osborn MK, Radziewicz H, Grakoui A, Workowski K. Acute hepatitis C and HIV coinfection. Lancet Infect Dis. 2009;9:775\u201383.","journal-title":"Lancet Infect Dis"},{"key":"745_CR12","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/QAI.0b013e3182a5c8d4","volume":"64","author":"PG Farnham","year":"2013","unstructured":"Farnham PG, Holtgrave DR, Gopalappa C, Hutchinson AB, Sansom SL. Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era. J Acquir Immune Defic Syndr. 2013;64:e15\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"745_CR13","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996."},{"key":"745_CR14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.280.13.1161","volume":"280","author":"ML Kamb","year":"1998","unstructured":"Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, Peterman TA. Efficacy of risk-reduction counseling to prevention human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT study group. J Am Med Assoc. 1998;280:1161\u20137.","journal-title":"J Am Med Assoc"},{"key":"745_CR15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199704103361512","volume":"336","author":"MH Katz","year":"1997","unstructured":"Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med. 1997;336:1097\u2013100.","journal-title":"N Engl J Med"},{"key":"745_CR16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V","volume":"9","author":"M Lothgren","year":"2000","unstructured":"Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ. 2000;9:623\u201330.","journal-title":"Health Econ"},{"key":"745_CR17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/09540120903373573","volume":"22","author":"NF Onen","year":"2010","unstructured":"Onen NF, Shacham E, Stamm KE, Overton ET. Comparisons of sexual behaviors and STD prevalence among older and younger individuals with HIV infection. AIDS Care. 2010;22:711\u20137.","journal-title":"AIDS Care"},{"key":"745_CR18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0277-9536(96)00258-4","volume":"44","author":"SD Pinkerton","year":"1997","unstructured":"Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303\u201312.","journal-title":"Soc Sci Med"},{"key":"745_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4899-1878-9_2","volume-title":"Handbook of economic evaluation of HIV prevention programs","author":"SD Pinkerton","year":"1998","unstructured":"Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave DR, editor. Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press; 1998. p. 13\u201332."},{"key":"745_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1022133716954","volume":"2","author":"SD Pinkerton","year":"1998","unstructured":"Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS Behav. 1998;2:189\u2013201.","journal-title":"AIDS Behav"},{"key":"745_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0193841X9802200201","volume":"22","author":"SD Pinkterton","year":"1998","unstructured":"Pinkterton SD, Holtgrave DR, Leviton LC, Wagstaff DA, Abramsom PR. Model-based evaluation of HIV prevention interventions. Eval Rev. 1998;22:155\u201374.","journal-title":"Eval Rev"},{"key":"745_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1010112619165","volume":"3","author":"SD Pinkterton","year":"2001","unstructured":"Pinkterton SD, Johnson-Masotti AP, Otto-Salaj LL, Stevenson LY, Hoffman RG. Cost-effectiveness of an HIV prevention intervention for mentally ill adults. Mental Health Serv Res. 2001;3:45\u201355.","journal-title":"Mental Health Serv Res"},{"key":"745_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archinte.164.1.46","volume":"164","author":"SD Pinkerton","year":"2004","unstructured":"Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med. 2004;164:46\u201354.","journal-title":"Arch Intern Med"},{"key":"745_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.qai.0000146598.40301.e6","volume":"38","author":"S Resch","year":"2005","unstructured":"Resch S, Altice FL, Paltiel AD. Cost-effectiveness of HIV screening for incarcerated pregnant women. J Acquir Immune Defic Syndr. 2005;38:163\u201373.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"745_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/00333549101250S111","volume":"125","author":"JP Ruger","year":"2010","unstructured":"Ruger JP, Abdallah AB, Cottler L. Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial. Public Health Rep. 2010;125(suppl 1):83\u201394.","journal-title":"Public Health Rep"},{"issue":"1","key":"745_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addbeh.2011.07.042","volume":"37","author":"JP Ruger","year":"2012","unstructured":"Ruger JP, Lazar CM. Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review. Addict Behav. 2012;37(1):1\u201310.","journal-title":"Addict Behav"},{"key":"745_CR27","doi-asserted-by":"crossref","first-page":"e33594","DOI":"10.1371\/journal.pone.0033594","volume":"7","author":"JP Ruger","year":"2012","unstructured":"Ruger JP, Abdallah AB, Luekens C, Cottler L. Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: a randomized controlled trial. PLoS One. 2012;7:e33594.","journal-title":"PLoS One"},{"key":"745_CR28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.290.2.228","volume":"290","author":"JA Salomon","year":"2003","unstructured":"Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. J Am Med Assoc. 2003;290:228\u201337.","journal-title":"J Am Med Assoc"},{"key":"745_CR29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/01.mlr.0000228021.89490.2a","volume":"44","author":"BR Schackman","year":"2006","unstructured":"Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44:990\u20137.","journal-title":"Med Care"},{"key":"745_CR30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0002-9343(01)00951-2","volume":"111","author":"ME Singer","year":"2001","unstructured":"Singer ME, Younossi ZM. Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. Am J Med. 2001;111:614\u201321.","journal-title":"Am J Med"},{"key":"745_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11524-008-9328-1","volume":"86","author":"B Tempalski","year":"2009","unstructured":"Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992\u20132002. J Urban Health. 2009;86:132\u201354.","journal-title":"J Urban Health"},{"key":"745_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s15010-004-3063-7","volume":"32","author":"G Verucchi","year":"2004","unstructured":"Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32:33\u201346.","journal-title":"Infection"},{"key":"745_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/sti.2009.036673","volume":"86","author":"DP Wilson","year":"2010","unstructured":"Wilson DP, Heymer KJ, Anderson J, O\u2019Connor J, Harcourt C, Donovan B. Sex workers can be screened too often: a cost-effectiveness analysis in Victoria, Australia. Sex Transm Infec. 2010;86:117\u201325.","journal-title":"Sex Transm Infec"},{"key":"745_CR34","volume-title":"Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization Department of HIV\/AIDS; 2001."},{"key":"745_CR35","volume-title":"Global Alert and Response","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Global Alert and Response. Geneva: World Health Organization. Hepatitis C; 2002."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-014-0745-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0745-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T16:43:30Z","timestamp":1716655410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-014-0745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s10461-014-0745-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}